The Global Antibiotic Research & Development Partnership (GARDP), a joint initiative by the World Health Organization and the Drugs for Neglected Diseases initiative, will soon launch REVIVE: an online hub to connect and support the antimicrobial discovery, research, and development community.
The aim of REVIVE is to champion and support a new generation of researchers in antimicrobial discovery, research, and development. REVIVE provides a space to connect and facilitate to clinical and non-clinical researchers entering the field access to world-class experts. So far, 120 experts have engaged in this endeavor.
REVIVE is also creating a reference repository of key tools and resources related to antimicrobial discovery, research, and development. REVIVE’s educational activities will include webinar series, roundtables, and workshops by leading experts to address critical steps along the pipeline of antimicrobial drug discovery and development.